Trump FTC Moves to Address Private Equity in Healthcare, Signals M&A Approvals; Chair Warns CEOs in March 2025

The Trump administration's Federal Trade Commission (FTC) is taking initial steps to address the role of private equity in the healthcare sector. Recent communications from the FTC indicate a willingness to expedite approvals for mergers and acquisitions (M&A) when they do not pose an economic threat to Americans. FTC Chair has warned CEOs that the agency will pursue legal action if it believes a merger or conduct could harm the public economically. This approach reflects a broader trend among global regulators who are signaling a desire for more deal approvals, as highlighted in various reports.